INTACEF TAZO PET 562.5 INJ

INTACEF TAZO PET 562.5 mg Injection is a broad-spectrum combination antibiotic containing Ceftazidime and Tazobactam for parenteral (injectable) use in veterinary patients. It provides powerful coverage against gram-negative organisms including Pseudomonas and beta-lactamase producing bacteria.

Composition: Ceftazidime 500 mg + Tazobactam 62.5 mg (562.5 mg) per vial.

Indications: Severe gram-negative bacterial infections. Septicaemia and bacteraemia. Hospital-acquired and drug-resistant infections. Pneumonia and respiratory infections. Urinary and wound infections unresponsive to first-line antibiotics.

Directions for Use: For intravenous or intramuscular administration by a qualified veterinarian. Reconstitute with sterile water for injection as per label instructions. Dosage and frequency as prescribed.

Suitable for: Dogs and cats. For use under veterinary supervision only.